XML 48 R13.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Supplemental Financial Information | 12 Months Ended
--- | ---
Dec. 31, 2024
Balance Sheet Related Disclosures [Abstract] |
Supplemental Financial Information | Supplemental Financial Information The following tables show the Company’s additional balance sheet information as of December 31, 2024 and 2023:
|  | As of December 31,
|  | 2024 |  | 2023
|  | (in thousands)
Inventories: |  |  |  |
Raw materials |  | $ | 103 |  |  | $ | — |
Work-in-progress |  | — |  |  | 100 |
Finished goods |  | 128 |  |  | 281 |
Inventory |  | $ | 231 |  |  | $ | 381 |
|  | As of December 31,
|  | 2024 |  | 2023
|  | (in thousands)
Accrued Liabilities: |  |  |  |
Accrued research and development services |  | $ | 12,251 |  |  | $ | 3,705 |
Accrued compensation and benefits |  | 14,712 |  |  | 9,591 |
Short term lease liability |  | 1,175 |  |  | 1,291 |
Other |  | 2,309 |  |  | 2,570 |
Accrued liabilities |  | $ | 30,447 |  |  | $ | 17,157 |
During the years ended December 31, 2024 and 2022 the Company incurred $1.1 million and $0.3 million, respectively, of severance expense reflected in research and development expenses. During the years ended December 31, 2024 and 2023 the Company incurred $11.2 million and $1.4 million, respectively, of severance expense reflected in selling, general, and administrative expenses. The Company incurred no severance costs in either research and development expenses in 2023 or selling, general, and administrative expenses in 2022. As of December 31, 2024 and 2023, $8.8 million and $0.7 million of severance is reflected as accrued compensation and benefits within accrued liabilities on the consolidated balance sheet as noted in the table above. As of December 31, 2024, $3.7 million of the total 2024 severance expense incurred had been paid. Approximately $7.7 million of the remaining December 31, 2024 accrued severance is expected to be paid by March 31, 2025.

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_BalanceSheetRelatedDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration